Wednesday, October 30, 2024
HomeIndustriesHealthcare

Healthcare

CytoReason Collaborates with Merck KGaA, Darmstadt, Germany, on Cancer Immunotherapy Drug

CytoReason, an Israeli company developing computational disease models for more efficient drug discovery and development, today announced a collaboration with German multinational science and...

Faster, Cheaper, More Reliable COVID-19 Tests Needed for the Unprecedented Demand Ahead

It may have its beginning for the UK travel industry, but there are signs of the end of using polymerase chain reaction, better known...

Findings from Vitality Study Provides Blueprint for Businesses to Avoid a Post-Pandemic Workplace Failure

A significant number of employees are anxious about having to adapt to a new way of working once again. Concern over returning to the...
0FansLike
0FollowersFollow
spot_img

Hot Topics